Effects of Recurrent PE on Women and Offspring
NCT05134285 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2021-12-08
Summary
The purpose of this study is to evaluate the risk factors of recurrent preeclampsia and compare the short-term and long-term adverse outcomes of women and their offspring.
Conditions
- Preeclampsia
- Recurrence
- Hypertension
Interventions
- OTHER
-
blood pressure,BMI, blood sample
Blood pressure will be monitored. BMI will be measured. Blood samples will be tested.
Sponsors & Collaborators
-
Dunjin Chen
lead OTHER
Eligibility
- Min Age
- 19 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-31
- Primary Completion
- 2024-11-30
- Completion
- 2024-11-30
Countries
- China
Study Locations
More Related Trials
-
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05089175 ·Status: UNKNOWN
-
Maternal Serum Markers Predicting Preeclampsia At Early Gestations
NCT05131282 ·Status: COMPLETED
-
China Obstetrics Alliance Cohort Study
NCT03038555 ·Status: UNKNOWN
-
The Effectiveness of Aspirin on Preventing Pre-eclampsia
NCT04656665 ·Status: UNKNOWN ·Phase: PHASE4
-
Prediction of Early Pre-eclampsia From Maternal Factors, Biophysical and Biochemical Markers at First Trimester
NCT02990767 ·Status: UNKNOWN
-
Oral Prophylactic Measures on the Occurrence of Pre-eclampsia (OP-PE)
NCT04989075 ·Status: COMPLETED ·Phase: NA
-
Inflammatory Biomarkers for the Diagnosis of oPRES
NCT05433870 ·Status: COMPLETED
-
Implementation of First-trimester Screening and preventiOn of pREeClAmpSia Trial (FORECAST)
NCT03941886 ·Status: COMPLETED ·Phase: NA
-
Prediction and Prevention of Preterm Birth (PREVENT-PTB Study)
NCT03530332 ·Status: TERMINATED ·Phase: NA
-
Preeclampsia Associated Vascular Aging
NCT04484766 ·Status: UNKNOWN
-
Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
NCT06802861 ·Status: RECRUITING
-
Serum LncRNAs as Early Potential Biomarkers for the Prediction of Preeclampsia
NCT03903393 ·Status: UNKNOWN
-
Cardiovascular Risk After Preeclampsia
NCT05277233 ·Status: RECRUITING
-
Study on Prevention, Treatment and Mechanism of Preterm Labor for Chinese Pregnant Women ≥35 Years Old
NCT03210415 ·Status: UNKNOWN
-
Prediction of Preeclampsia (PE) at 11-13 Week
NCT03554681 ·Status: COMPLETED
-
Environmental Factors and Embryonic Development Project
NCT04182503 ·Status: UNKNOWN
-
Risk Prediction Models for Adverse Maternal and Neonatal Outcomes in Preeclampsia
NCT04058405 ·Status: COMPLETED
-
Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China
NCT01804751 ·Status: UNKNOWN
-
Role of Vaspin in Pathophysiology of Pre-eclampsia
NCT06437535 ·Status: NOT_YET_RECRUITING
-
Interest of Circulating Endothelial Biomarkers in Vascular Pregnancy Complications
NCT00485784 ·Status: COMPLETED ·Phase: NA
-
The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center
NCT06383858 ·Status: RECRUITING
-
Low Dose Aspirin in the Prevention of Preeclampsia in China
NCT02797249 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Single Umbilical Artery Caused by Umbilical Artery Embolism on Pregnancy Outcome
NCT05327036 ·Status: UNKNOWN
-
Mothers Working to Prevent Early Stillbirth Study 20-28
NCT06005272 ·Status: RECRUITING
-
KW-3357 Study in Patients With Early Onset Severe Preeclampsia
NCT04182373 ·Status: COMPLETED ·Phase: PHASE3